Fertility: Fertility studies have not been performed.
Pregnancy: Animal studies have indicated that atracurium has no significant effects on foetal development.
In common with all neuromuscular blocking agents, atracurium should be used during pregnancy only if the potential benefit to the mother outweighs any potential risk to the foetus.
Atracurium is suitable for maintenance of muscle relaxation during Caesarean section as it does not cross the placenta in clinically significant amounts following recommended doses.
Lactation: It is not known whether atracurium is excreted in human milk.